Clinical trial
Post-Authorization Safety Study: Risk of Out-of-Hospital Sudden Cardiac Death in Users of Domperidone, Users of Proton Pump Inhibitors, and Users of Metoclopramide
NCT01907633 is registered in ClinicalTrials.gov with Janssen Research & Development, LLC as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Post-Authorization Safety Study: Risk of Out-of-Hospital Sudden Cardiac Death in Users of Domperidone, Users of Proton Pump Inhibitors, and Users of Metoclopramide
- Lead sponsor
- Janssen Research & Development, LLC
- Phase
- Observational
- Overall status
- Completed
- Start date
- December 31, 2011
- Completion date
- December 31, 2013
- Enrollment
- 15,000 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.